pharma · Malaria · Pharmacokinetics · CNSP
CNS Pharmaceuticals
CNS Pharmaceuticals is a pharma organization headquartered in Houston, USA. It trades on NYSE under ticker CNSP. Primary therapeutic focus areas include Malaria, Pharmacokinetics, Ovarian Cancer, Glioblastoma multiforme
Houston, TX 77027, US HQ
2017 Founded
12 Employees
Public company Type
CNSP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Houston, TX 77027, US
- Founded
- 2017
- Employees
- 12
- Programs
- 21
- Drugs
- 18
- Patents
- 0
Berubicin
Phase 2 · small molecule · Glioblastoma Multiforme, Adult
Berubicin for Glioblastoma Multiforme, Adult is a Phase 2 program (small_molecule) at CNS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code CNS-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CNS Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Glioblastoma Multiforme, Adult
- Status
- active
- Trials
- 1